A well-defined regulatory context

Effectiveness acknowledged by the authorities

Lactium® received the authorization from the DGCCRF (approved by the AFSSA) for the following health claim (at a dosage of 150mg/day):

“ … can moderate the tense response to stress, especially for highly sensitive persons”.

Moreover, Lactium® is on the EHPM/CIAA list, waiting to receive a European health claim authorization from the EFSA (European Food Safety Agency) in 2010 (EEC Regulation 1924/2006 art. 13 and 21.)

Consumer-friendly labelling

• In Europe and Asia, Lactium® can be labelled as: “ milk protein hydrolysate ”
• In the United States, Lactium® can be labelled as: “ casein hydrolysate ”

Lactium® was approved by the FDA and benefits from GRAS and NDI (New Dietary Ingredient) status in the United States.

An ingredient protected by several patents

Lactium® is protected by several international patents in Europe, the United States and Japan.

For further information on the regulatory constraints related to the use of Lactium®, please feel free to contact us.